A. Hartley

Queen Elizabeth Hospital Birmingham — United Kingdom

Medicine · Health Sciences

26h-index5.0kcitations166works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(98), Advanced Radiotherapy Techniques(26), Radiomics and Machine Learning in Medical Imaging(24), Brain Metastases and Treatment(19), Head and Neck Surgical Oncology(18)

Publications165 total

NG11-2 phase-Ib trial to prevent/reduce severe oral mucositis induced by radiotherapy.
Journal of Clinical Oncology·2025
1386 Impact of the introduction of “5+5” contouring on efficacy and swallowing outcomes in the phase 3 randomised CompARE trial.
Radiotherapy and Oncology·2025
Outcomes of Patients With Five or More Brain Metastases Treated With Stereotactic Radiosurgery From 2014 to 2019: A UK Series
Clinical Oncology·2024Open Access
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (<scp>HNSCC</scp>) in the <scp>UK</scp>
International Journal of Cancer·2024· 3 citedOpen Access
Supplementary Data 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 4 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Data from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Table 2 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 3 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Table 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 2 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Table 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 2 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Supplementary Data 1 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 3 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Figure 4 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Data from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
Table 2 from Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Paul Sanghera(25), Hisham Mehanna(17), J. Glaholm(12), Max Robinson(7), Anthony Kong(7), J I Geh(7), Kevin J. Harrington(6), Christopher C. McConkey(6), Janet Dunn(6), C. McConkey(6), Helen Benghiat(6), Charles Fong(6), Mehmet Şen(5), L. O’Toole(4), E. Aynsley(4), Andrew K. Chan(4), Paul Nankivell(4), Chris Nutting(4), Selvaraj Giridharan(4), Sara Meade(4)